search forPfizer Caribe Limited

Region
Status
goods and services
Instead search for Pfizer Caribe (21 Results)
Class(es)
EUIPO
5
03/11/2005
02/09/2006
03/11/2015
Registration expired
EUIPO
1644
09/30/2004
-
-
Application refused
EUIPO
44
07/20/2004
-
-
Application refused
IGE
5
06/20/2000
11/17/2000
06/20/2010
Trademark cancelled
IGE
5
05/25/2000
11/01/2000
05/25/2010
Trademark cancelled
IGE
5
05/25/2000
11/01/2000
05/25/2010
Trademark cancelled
EUIPO
5
05/16/2000
07/12/2001
-
Registration surrendered
EUIPO
5
05/15/2000
07/19/2001
05/15/2010
Registration expired
EUIPO
5
04/27/2000
04/12/2001
04/27/2010
Registration expired
EUIPO
5
04/07/2000
05/29/2001
-
Registration surrendered

That’s Why a Free TMDB Account Is Worthwhile

Monitor and protect brands

If you have set up trademark monitoring, you will automatically receive an email about copycats and free riders. This is how uncomplicated real-time brand protection works.

Follow brands easily

If you follow a trade mark, you will receive an e-mail when new applications, oppositions, deadlines, renewals and much more are filed. - This way, you can stay up to date on the development of a trade mark.

Sign up for free
EUIPO
5
04/07/2000
10/09/2001
04/07/2010
Registration expired
EUIPO
5
12/21/1999
03/27/2001
12/21/2009
Registration expired
EUIPO
5
10/15/1999
-
-
Application withdrawn
EUIPO
5
09/16/1999
-
-
Application withdrawn

That’s Why a Free TMDB Account Is Worthwhile

Monitor and protect brands

If you have set up trademark monitoring, you will automatically receive an email about copycats and free riders. This is how uncomplicated real-time brand protection works.

Follow brands easily

If you follow a trade mark, you will receive an e-mail when new applications, oppositions, deadlines, renewals and much more are filed. - This way, you can stay up to date on the development of a trade mark.

Sign up for free

Search results 1 - 14 of 14

We love brands.
And are happy to look after you.

You can reach us from Monday to Friday between 08:00-16:00.

Kontaktieren Sie uns.